Recent progress on the molecular aspects of endocrine tumors : clinical implications, 39es Journées Internationales Henri-Pierre Klotz d'Endocrinologie Clinique, Paris, 30-31 mai 1996 39th International Henri-Piere Klotz Symposium on Clinical Endocrinology, Paris, May 30-31, 1996
Author(s)
Bibliographic Information
Recent progress on the molecular aspects of endocrine tumors : clinical implications, 39es Journées Internationales Henri-Pierre Klotz d'Endocrinologie Clinique, Paris, 30-31 mai 1996 = 39th International Henri-Piere Klotz Symposium on Clinical Endocrinology, Paris, May 30-31, 1996
（Hormone research, v. 47,
Karger, 1997
Available at / 3 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Presents the proceedings of the 39th International Henri-Pierre Klotz Symposium on Hormone Binding Proteins, held in Paris, May 1996. The text focuses on the clinical applications of recent progress on the molecular aspects of endocrine tumours.
Table of Contents
- Targeted oncogenesis in the thyroid of transgenic mice, J. Feunteun et al
- protein kinase C alpha and tumorigenesis of the endocrine gland, C. Prevostel et al
- origin and progression of thyroid epithelial tumors - cellular and molecular mechanisms, D. Wynford-Thomas
- clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia, J. Leclere et al
- targetting medullary thyroid carcinomas with bispecific antibodies and bivalent haptens, E. Rouvier et al
- RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma, D.J. Marsh et al
- multiple endocrine neoplasia type 1 and the search for the genetic trigger, F. Farnebo et al
- tumor suppressor genes in the pathogenesis of human pituitary tumors, R.N. Clayton et al
- molecular mechansism of parathyroid hyperplasia and neoplasia, M.L. Brandi
- genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia, A. Calender et al
- management of patients and subjects at risk for multiple endocrine neoplasia type 1 - MEN 1, P. Chanson et al
- multiple endocrine neoplasia type 2 - management of patients and subjects at risk, B. Conte-Devolx et al
- abnormal transduction mechanisms in pituitary adenomas, A. Barlier et al
- cyclic AMP and calcium in the transduction of hypothalamic neurohormone action in human pituitary tumors, A. Spada et al
- nerve growth factor suppresses the tumoral phenotype of human prolactinomas, C. Missale et al
- effects of the cAMP pathway activation in somatotrophs, J. Bertherat
- pit-1 gene expression in human pituitary adenomas, I. Pellegrini-Bouiller et al
- V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors, Y. de Keyzer et al
- genetic alterations of the RET proto-oncogene in familial and sporadic phenochromocytomas, P. Rodien et al
- molecular markers for malignancy in andrenocortical tumors, C. Gicquel and Y. LeBouc
- adrenocorticotropin receptor and adrenal disorders, B. Allolio and M. Reincke
- adrenal incidentaloma - an overview of clinical and epidemiological data from the National Italian Study Group, A. Angeli et al
- adrenal incidentaloma - an overview of hormonal data from the National Italian Study Group, F. Mantero et al.
by "Nielsen BookData"
